Arcus Biosciences, Inc. (NYSE:RCUS) Expected to Post FY2024 Earnings of ($2.64) Per Share

Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Stock analysts at Wedbush raised their FY2024 EPS estimates for Arcus Biosciences in a research report issued on Tuesday, January 30th. Wedbush analyst R. Driscoll now forecasts that the company will post earnings per share of ($2.64) for the year, up from their previous estimate of ($4.11). […]

Leave a Reply

Your email address will not be published.

Previous post Q1 2024 EPS Estimates for Washington Trust Bancorp, Inc. (NASDAQ:WASH) Reduced by Analyst
Next post Chicago Bears zero in on Chris Beatty — DJ Moore’s college position coach — as their wide receivers coach